Researchers at NYU Langone’s Grossman School of Medicine have found that a computerised brain implant could efficiently alleviate short-term and chronic pain in a new preclinical study.

This data could be a ‘blueprint’ for creating brain implants to treat pain syndromes as well as other brain-based disorders, including anxiety, depression and panic attacks, the scientists noted.

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

According to the study, rodents with the implant withdrew their paws 40% more slowly from sudden pain as against times when the device was switched off.

This indicates that the computer-controlled device lowered the pain intensity experienced by the animals, study authors said.

Furthermore, rodents in sudden or continuous pain spent more time in a chamber where the device was turned on by nearly two-thirds compared to a chamber where the device was off.

Using a closed-loop brain-machine interface technology, the implant senses brain activity in the anterior cingulate cortex, a brain region vital for pain processing.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

Subsequently, a computer connected to the device automatically detects electrical patterns in the brain closely associated with pain.

On detecting signs of pain, the computer induces treatment stimulation of the prefrontal cortex region of the brain, to relieve the pain.

Furthermore, the device works only in the presence of pain, thereby lowering the risk of overuse and possible tolerance in the future.

Unlike opioids, the implant offers no further rewards, so would provide pain relief with a low risk of addiction.

In the study, the implant was able to precisely detect pain up to 80% of the time, the institute noted.

NYU Langone Perioperative Care and Pain Medicine anaesthesiology department doctoral fellow and lead study investigator Qiaosheng Zhang said: “Our results demonstrate that this device may help researchers better understand how pain works in the brain.

“Moreover, it may allow us to find non-drug therapies for other neuropsychiatric disorders, such as anxiety, depression and post-traumatic stress.”

The US National Institutes of Health (NIH) funded the study, which is the first to test a computerised brain implant to identify and relieve pain in real-time.

Currently, the researchers are planning to study less invasive versions of the brain implant with the potential for use in humans.

Medical Device Network Excellence Awards - Nominations Closed

Nominations are now closed for the Medical Device Network Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact

Excellence in Action
HemoSonics has won the 2025 Marketing Award for its impactful promotion of theQuantra Hemostasis System and leadership in blood management education. See how targeted campaigns, thought leadership content, and hands on clinician training are accelerating Quantra’s market traction and shaping the future of hemostasis testing.

Discover the Impact